Recorded on: March 23, 2023
1.0 CME Credit for physician assistants available until: March 23, 2024
1.0 CE Credit/Contact hour for nurses and nurse practitioners available until: June 30, 2024
Format: Non-interactive recorded webinar
This CE activity is intended for oncology nurses, PAs, and other healthcare professionals involved in the care of patients with blood cancer.
After completing this CE activity, the participant should be better able to:
- Describe the goals and types of hematopoietic cell transplantation used in the treatment of blood cancers, including autologous, allogeneic, and reduced-intensity allogeneic stem-cell transplantation
- Describe the indications for hematopoietic stem cell transplant
- Explain the process of pre-transplant evaluation, mobilization, cell collection, and cell infusion in patients with blood cancer
- Explain the short and long-term follow up requirements
- Identify resources for patient education and support
Krishna Komanduri, MD
Julius R. Krevans Distinguished Professor of Medicine
Chief, UCSF Health Division of Hematology/Oncology
Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
Corinne Shamehdi, MPAS, PA-C
Inpatient Lead APP
Tampa General Hospital Cancer Institute
Continuing Education Information
Registered Nursing Credit Designation
Approval for nurses has been obtained by The Leukemia & Lymphoma Society National Office under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Nurse Practitioner Credit Designation
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.00 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23056141. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Physician Assistant Credit Designation
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid from 3/23/2023 to 3/23/2024. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-206402.
ILNA Recertification Points
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas: Care Continuum (ONC, CBCN, CPHON, AOCNP), Care of the Pediatric Hematology and Oncology Patient (CPHON), Cellular Collection, Preparative Regimens, and Infusion (BMTCN), Disease Related Biology (CPHON), Early Post-Transplant Management and Education (BMTCN), Foundations of Transplant (BMTCN), Health Maintenance (CPHON), Late Post-Transplant Management and Education (BMTCN), Professional Practice/Performance (BMTCN, AOCNP), Psychosocial Dimensions of Care (AOCNP, CPHON, ONC, CBCN), Quality of Life (BMTCN), Transplant Process and Infusion (BMTCN), Treatment (OCN, CBCN, AOCNP, CPHON).
Total points: 1.0*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.
There are no fees for participating in or receiving credit for this CE activity.
This activity is developed through a collaboration between The Leukemia & Lymphoma Society and The AAPA African Heritage PA Caucus.
There is no commercial support associated with this CE activity.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.